Other search tools

About this data

The publication data currently available has been vetted by Vanderbilt faculty, staff, administrators and trainees. The data itself is retrieved directly from NCBI's PubMed and is automatically updated on a weekly basis to ensure accuracy and completeness.

If you have any questions or comments, please contact us.

Results: 1 to 10 of 48

Publication Record

Connections

Hepatitis C Coinfection and Mortality in People Living with HIV in Middle Tennessee.
Hall T, Jenkins CA, Hulgan T, Furukawa S, Turner M, Pratap S, Sterling TR, Tabatabai M, Berthaud V
(2020) AIDS Res Hum Retroviruses 36: 193-199
MeSH Terms: Adolescent, Adult, Aged, Ambulatory Care Facilities, Antiviral Agents, Female, HIV Infections, Hepatitis C, Hepatitis C, Chronic, Humans, Male, Middle Aged, Proportional Hazards Models, Retrospective Studies, Risk Factors, Sexual and Gender Minorities, Substance Abuse, Intravenous, Tennessee, Viral Load, Young Adult
Added December 11, 2019
0 Communities
1 Members
0 Resources
20 MeSH Terms
Broadly Neutralizing Antibody Mediated Clearance of Human Hepatitis C Virus Infection.
Kinchen VJ, Zahid MN, Flyak AI, Soliman MG, Learn GH, Wang S, Davidson E, Doranz BJ, Ray SC, Cox AL, Crowe JE, Bjorkman PJ, Shaw GM, Bailey JR
(2018) Cell Host Microbe 24: 717-730.e5
MeSH Terms: Animals, Antibodies, Monoclonal, Antibodies, Neutralizing, Antibody Specificity, Base Sequence, Binding Sites, Cell Line, Cricetulus, Epitopes, Female, HEK293 Cells, HIV-1, Hepacivirus, Hepatitis C, Hepatitis C Antibodies, Humans, Immunologic Memory, Male, Models, Molecular, Mutagenesis, Site-Directed, Viral Envelope Proteins, Viral Load
Added March 31, 2019
0 Communities
1 Members
0 Resources
22 MeSH Terms
HCV Broadly Neutralizing Antibodies Use a CDRH3 Disulfide Motif to Recognize an E2 Glycoprotein Site that Can Be Targeted for Vaccine Design.
Flyak AI, Ruiz S, Colbert MD, Luong T, Crowe JE, Bailey JR, Bjorkman PJ
(2018) Cell Host Microbe 24: 703-716.e3
MeSH Terms: Antibodies, Neutralizing, Antibodies, Viral, Binding Sites, Disulfides, Drug Design, Epitopes, Hepacivirus, Hepatitis C, Hepatitis C Antibodies, Humans, Immunoglobulin G, Models, Molecular, Protein Conformation, Sequence Alignment, Viral Envelope Proteins, Viral Hepatitis Vaccines, X-Ray Diffraction
Added March 31, 2019
0 Communities
1 Members
0 Resources
17 MeSH Terms
Synergistic anti-HCV broadly neutralizing human monoclonal antibodies with independent mechanisms.
Mankowski MC, Kinchen VJ, Wasilewski LN, Flyak AI, Ray SC, Crowe JE, Bailey JR
(2018) Proc Natl Acad Sci U S A 115: E82-E91
MeSH Terms: Antibodies, Monoclonal, Antibodies, Neutralizing, HEK293 Cells, Hepacivirus, Hepatitis Antibodies, Hepatitis C, Humans, Viral Hepatitis Vaccines
Added March 14, 2018
0 Communities
1 Members
0 Resources
8 MeSH Terms
Transcriptomic Analysis of Chronic Hepatitis B and C and Liver Cancer Reveals MicroRNA-Mediated Control of Cholesterol Synthesis Programs.
Selitsky SR, Dinh TA, Toth CL, Kurtz CL, Honda M, Struck BR, Kaneko S, Vickers KC, Lemon SM, Sethupathy P
(2015) mBio 6: e01500-15
MeSH Terms: Carcinoma, Hepatocellular, Cholesterol, Gene Expression Profiling, Gene Expression Regulation, Genetic Markers, Hepatitis B, Chronic, Hepatitis C, Chronic, High-Throughput Nucleotide Sequencing, Humans, Liver, Liver Neoplasms, MicroRNAs
Added April 25, 2016
0 Communities
1 Members
0 Resources
12 MeSH Terms
Three months of weekly rifapentine plus isoniazid is less hepatotoxic than nine months of daily isoniazid for LTBI.
Bliven-Sizemore EE, Sterling TR, Shang N, Benator D, Schwartzman K, Reves R, Drobeniuc J, Bock N, Villarino ME, TB Trials Consortium
(2015) Int J Tuberc Lung Dis 19: 1039-44, i-v
MeSH Terms: Adult, Antitubercular Agents, Aspartate Aminotransferases, Brazil, Canada, Case-Control Studies, Chemical and Drug Induced Liver Injury, Drug Administration Schedule, Drug Therapy, Combination, Female, Hepatitis C, Humans, Isoniazid, Latent Tuberculosis, Male, Middle Aged, Multivariate Analysis, Rifampin, Risk Factors, Spain, United States
Added February 17, 2016
0 Communities
1 Members
0 Resources
21 MeSH Terms
Comparison of functional variants in IFNL4 and IFNL3 for association with HCV clearance.
O'Brien TR, Pfeiffer RM, Paquin A, Lang Kuhs KA, Chen S, Bonkovsky HL, Edlin BR, Howell CD, Kirk GD, Kuniholm MH, Morgan TR, Strickler HD, Thomas DL, Prokunina-Olsson L
(2015) J Hepatol 63: 1103-10
MeSH Terms: Alleles, Antiviral Agents, Female, Genotype, Hepacivirus, Hepatitis C, Chronic, Humans, Interferons, Interleukins, Male, Middle Aged, Polymorphism, Genetic, RNA, Viral
Added August 15, 2017
0 Communities
1 Members
0 Resources
13 MeSH Terms
Injection Drug Use and Hepatitis C as Risk Factors for Mortality in HIV-Infected Individuals: The Antiretroviral Therapy Cohort Collaboration.
May MT, Justice AC, Birnie K, Ingle SM, Smit C, Smith C, Neau D, Guiguet M, Schwarze-Zander C, Moreno S, Guest JL, Monforte Ad, Tural C, Gill MJ, Bregenzer A, Kirk O, Saag M, Sterling TR, Crane HM, Sterne JA
(2015) J Acquir Immune Defic Syndr 69: 348-54
MeSH Terms: Adolescent, Adult, Anti-HIV Agents, CD4 Lymphocyte Count, Cohort Studies, Female, HIV Infections, Hepatitis C, Humans, Male, Middle Aged, Risk Factors, Substance Abuse, Intravenous, Survival Analysis, Treatment Outcome, Viral Load, Young Adult
Added February 17, 2016
0 Communities
1 Members
0 Resources
17 MeSH Terms
Development of anti-factor XIII antibodies in a patient with hereditary factor XIII deficiency receiving therapy for chronic hepatitis C.
Sosa R, Gailani D, Neff AT
(2014) Haemophilia 20: e429-32
MeSH Terms: Adult, Antibodies, Antiviral Agents, Blood Coagulation Factor Inhibitors, Factor XIII, Factor XIII Deficiency, Female, Hepatitis C, Chronic, Humans, Immunosuppressive Agents, Treatment Outcome
Added January 20, 2015
0 Communities
1 Members
0 Resources
11 MeSH Terms
Addition of nitazoxanide to PEG-IFN and ribavirin to improve HCV treatment response in HIV-1 and HCV genotype 1 coinfected persons naïve to HCV therapy: results of the ACTG A5269 trial.
Amorosa VK, Luetkemeyer A, Kang M, Johnson VA, Umbleja T, Haas DW, Yesmin S, Bardin MC, Chung RT, Alston-Smith B, Tebas P, Peters MG
(2013) HIV Clin Trials 14: 274-83
MeSH Terms: Adult, Animals, Antiviral Agents, Drug Therapy, Combination, Female, HIV Infections, HIV-1, Hepacivirus, Hepatitis C, Humans, Interferon-alpha, Male, Middle Aged, Nitro Compounds, Pilot Projects, Polyethylene Glycols, Recombinant Proteins, Ribavirin, Thiazoles
Added March 13, 2015
0 Communities
1 Members
0 Resources
19 MeSH Terms